ERB Revenue second quarter 2015 Y/Y Growth Comment
Erba Diagnostics, Inc. reported fall in Revenue in the second quarter 2015 by -13.71% to $ 5.95 millions, from the same quarter in 2014. The decline in the second quarter 2015 Erba Diagnostics, Inc.'s Revenue compares unfavorably to the Company's average Revenue rise of 26.61%.
Looking into second quarter 2015 results within Laboratory Analytical Instruments industry 19 other companies have achieved higher Revenue growth. While Erba Diagnostics, Inc.' s Revenue decrease of -13.71% ranks overall at the positon no. 3349 in the second quarter 2015.
Revenue by Quarter for the Fiscal Years 2012, 2013, 2014, 2015
Erba Diagnostics,'s Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
196.8 %
20.21 %
-40.35 %
(Dec 31 2012)
ERB's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2015 Erba Diagnostics, Inc. disclosed decline in Revenue from the first quarter by -6.66% to $ 5.95 millions, from $ 6.37 millions achived in the previous reporting period.
Although periodic circumstance commonly energize II. Quarter 2015 Revenue, this plainly could not be substantial to rescue Laboratory Analytical Instruments's company achievement, Most analysts pointed out.
Within Laboratory Analytical Instruments industry 19 other companies have achieved higher Revenue quarter on quarter growth. While Erba Diagnostics,'s Revenue growth quarter on quarter, overall rank is 3270.
In the II. Quarter 2015 Erba Diagnostics, Inc. disclosed decline in Revenue from the first quarter by -6.66% to $ 5.95 millions, from $ 6.37 millions achived in the previous reporting period.
Although periodic circumstance commonly energize II. Quarter 2015 Revenue, this plainly could not be substantial to rescue Laboratory Analytical Instruments's company achievement, Most analysts pointed out.
Within Laboratory Analytical Instruments industry 19 other companies have achieved higher Revenue quarter on quarter growth. While Erba Diagnostics,'s Revenue growth quarter on quarter, overall rank is 3270.
Erba Diagnostics,'s 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2015)
12 Months Ending (Mar 31 2014)
12 Months Ending (Dec 31 2013)
12 Months Ending (Jun 30 2013)
12 Months Ending (Mar 31 2013)
Cumulative Revenue 12 Months Ending
$ 26.97
$ 27.92
$ 28.26
$ 28.63
$ 26.06
Y / Y Revenue Growth (TTM)
10.74 %
28.16 %
-
-
-
Year on Year Revenue Growth Overall
Ranking
# 1430
# 2953
# 0
# 0
# 0
Seqeuential Revenue Change (TTM)
-3.38 %
-1.19 %
-11.1 %
9.88 %
-
Seq. Revenue Growth (TTM) Overall
Ranking
# 1204
# 3120
# 0
# 0
# 0
Cumulative Revenue growth Comment
Assuming the Erba Diagnostics,'s fiscal year would have ended in Jun 30 2015, Erba Diagnostics, would have reprted above average annual Revenue increase of 10.74% year on year, of $ 27 millions. This marks a slow-down of the companys growth trends and from the 28.16% improvement in Mar 31 2014.
In the Healthcare sector 194 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1430, from total ranking in previous quarter at 2953.
Assuming the Erba Diagnostics,'s fiscal year would have ended in Jun 30 2015, Erba Diagnostics, would have reprted above average annual Revenue increase of 10.74% year on year, of $ 27 millions. This marks a slow-down of the companys growth trends and from the 28.16% improvement in Mar 31 2014.
In the Healthcare sector 194 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1430, from total ranking in previous quarter at 2953.
About Erba Diagnostics, Revenue Growth Rates (ERB), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
